Skip to content

Pfizer recalls millions of pills due to risk of poisoning in children

Pfizer recalls millions of pills due to risk of poisoning in children

Pfizer has recalled more than four million packages of Nurtec ODT due to the risk of poisoning in children. The recall was announced by the US Consumer Product Safety Commission (CPSC).

Pfizer is recalling the medication, which is commonly used to treat migraines, because it is currently in a blister pack that is not considered “child-resistant” and therefore poses a potential risk to children. “Child-resistant” packaging must obviously pose a significant challenge for a child under the age of five to open, the CPSC says.

According to the safety commission, users of Nurtec ODT can contact Pfizer to receive a free child-proof bag to put the medicine.

Nurtec ODT #Recall to provide child proof bags to patients to store their medicines. Click the link for more information. https://t.co/B9zEvxLulC pic.twitter.com/MmCnL6DDA0

— Nurtec® ODT (@rimegepant) (@NurtecODT) March 16, 2023

“The recalled prescription drugs must be in child-resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child-resistant, and poses a risk of poisoning if the contents are swallowed by young children,” the CPSC said.

Pfizer is recalling 4.2 million packages of Nurtec ODT, which contain eight 75 mg disintegrating tablets each. The Poison Prevention Safety Act (PPPA) requires this medicine to be in a child-resistant container.

“The tablets are contained in a non-child-resistant blister card packaged in a carton that includes the product name, dosage, NDC number and expiration date,” the safety commission said.

Pharmacies across the country sold the drug packs from December 2021 to March 2023.

Nurtec’s statement explains that there is no need to return Nurtec packages and adds that “withdrawal” refers to any situation where a product requires repair, replacement, refund or notice/warning.

In 2022, Pfizer reported revenue of 100.3 billion dollars, a historic high for the pharmaceutical company. He attributed the growth in his income to Paxlovid and Comirnaty, the trade name for their Covid mRNA vaccine.

NOW READ:

BREAKING: Donald Trump’s YouTube channel has been restored

*” Indicates mandatory fields


OPINION:
This article contains comments that reflect the opinion of the author.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish